Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA ephedrine proposal comment deadline extension urged by Reps. Boyd, Farr.

This article was originally published in The Tan Sheet

Executive Summary

FDA EPHEDRINE PROPOSAL COMMENT EXTENSION URGED BY REPS. BOYD, FARR in recent letters to the agency. Allen Boyd (D-Fla.) and Sam Farr (D-Calif.) support the allowance of additional time to facilitate public input to the proposed rule, which would establish serving limits and label warnings for dietary supplements containing ephedrine alkaloids ("The Tan Sheet" June 9, pp. 20-23). Rep. Boyd, a member of the House Small Business Committee, states in a Nov. 12 letter that "the management of this rule has made it difficult, if not impossible, for small businesses to participate in the rulemaking process."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087824

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel